日本語English简体中文 繁體中文

504A Innovacell Inc.イノバセルTSE Growth / Pharmaceuticals

0 posts

Innovacell Inc. (504A) at a glance

Code
504A
Company
Innovacell Inc.
Local name
イノバセル
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥446 -28.0 (-5.91%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Innovacell Inc. (504A) Stock Price History

Innovacell Inc. closed at ¥446 on Nov 20, 2026, −7.5% over 1 month.

2026-11-11 2026年12月期第3四半期決算短信〔日本基準〕(連結)¥511¥444Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥511Oct 21
1-Month Low¥444Nov 6
1-Week Change−10.1%vs Nov 13
1-Month Change−7.5%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥92,531 today (−7.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −7.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥446−28−5.91%
Nov 19 (Thu)¥474+3+0.64%
Nov 18 (Wed)¥471−4−0.84%
Nov 17 (Tue)¥475−30−5.94%
Nov 16 (Mon)¥505+9+1.81%
Nov 13 (Fri)¥496−7−1.39%
Nov 12 (Thu)¥503−5−0.98%
Nov 11 (Wed)¥508+6+1.20%
Nov 10 (Tue)¥502+11+2.24%
Nov 9 (Mon)¥491+47+10.59%
2026-11-11 2026年12月期第3四半期決算短信〔日本基準〕(連結)¥633¥444Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥633Aug 21
3-Month Low¥444Nov 6
1-Month Change−7.5%vs Oct 20
3-Month Change−24.5%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥75,465 today (−24.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −24.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥446−28−5.91%
Nov 19 (Thu)¥474+3+0.64%
Nov 18 (Wed)¥471−4−0.84%
Nov 17 (Tue)¥475−30−5.94%
Nov 16 (Mon)¥505+9+1.81%
Nov 13 (Fri)¥496−7−1.39%
Nov 12 (Thu)¥503−5−0.98%
Nov 11 (Wed)¥508+6+1.20%
Nov 10 (Tue)¥502+11+2.24%
Nov 9 (Mon)¥491+47+10.59%
2026-11-11 2026年12月期第3四半期決算短信〔日本基準〕(連結)¥710¥385May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥710May 22
6-Month Low¥385Jun 26
3-Month Change−24.5%vs Aug 20
6-Month Change−32.6%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥67,372 today (−32.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −32.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥446−10.4%
Oct 2026¥498−21.2%
Sep 2026¥632+8.4%
Aug 2026¥583+7.8%
Jul 2026¥541+32.0%
Jun 2026¥410−27.6%
May 2026¥566−6.1%
2026-11-11 2026年12月期第3四半期決算短信〔日本基準〕(連結)¥1,073¥385Feb 24Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥1,073Mar 13
52-Week Low¥385Jun 26
Year to Date―
From 52-Week High−58.4%Mar 13

If you had invested ¥100,000 1 year ago, it would be worth ¥42,476 today (−57.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −1.5%, while this stock moved −57.5%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥446−10.4%
Oct 2026¥498−21.2%
Sep 2026¥632+8.4%
Aug 2026¥583+7.8%
Jul 2026¥541+32.0%
Jun 2026¥410−27.6%
May 2026¥566−6.1%
Apr 2026¥603−24.9%
Mar 2026¥803−15.8%
Feb 2026¥954―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2026). Please check the latest prices before trading.

Innovacell Inc. (504A) financial indicators

PBR
2.29
ROE
-41.86%
Dividend yield
0.00%

See all financial indicators for Innovacell Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Innovacell Inc. (504A)

Business overview

The company researches and develops cell therapy products using human cells. Its technology prepares myoblasts from a patient's own muscle tissue and injects them into damaged or weakened muscle to restore function. It focuses on urinary and fecal incontinence, and its most advanced candidate, ICEF15 for urge fecal incontinence, is in an international Phase III trial.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR2.29xAbove the sector median of 1.86x (No. 48 from the lowest)
ROE-41.86%No. 43 in the sector (highest first); median 4.17%
Market cap¥20.1 bnNo. 38 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

High since 2/24¥1,0733/13
Low since 2/24¥3856/26
Current position8.9%Where the low is 0% and the high is 100% (close on 11/20: ¥446)

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers2 timesLatest: 11/9 (No. 43)
Top 50 losers1 timesLatest: 10/19 (No. 47)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (3).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Innovacell Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English